Lung Cancer News

NEW YORK — In this video commentary from HemOnc Today New York, Taofeek K. Owonikoko, MD, PhD, discussed the existing and emerging evidence of immunotherapy for the frontline treatment of patients with advanced lung cancer.

Physical inactivity appeared linked with an increased risk for lung cancer, according to findings published in Cancer Treatment and Research Communications.

The FDA’s Tobacco Products Scientific Advisory Committee recently ruled that several of the claims made by Philip Morris for the intention of using in its marketing and labelling its IQOS cigarette were invalid.

Researchers at Johns Hopkins Kimmel Cancer Center developed a test that they say identifies several types of cancers in early stages.

by Leah Christl, PhD

Risk-targeted low-dose CT testing is the most effective approach to reduce lung cancer mortality; however, gains in benefits, such as life-years saved, quality-adjusted life-years and cost-effectiveness, are not substantial, according to two studies published in Annals of Internal Medicine.

Scientists and engineers at The University of Texas at Austin have invented a handheld device called the MasSpec Pen designed to rapidly and accurately identifies cancerous tissue during surgery.

The addition of intraoperative molecular imaging and preoperative PET scan led to the identification and removal of significantly more cancerous nodules than PET scan alone for patients with resectable lung cancer, according to study results published in Annals of Surgery.

A trial at University of Colorado Cancer Center is designed to evaluate the potential of an inhaled form of the pulmonary hypertension drug iloprost to heal lung damage among former smokers and prevent progression to cancer.

Lung Cancer Awareness Month — observed in November — is intended to educate the public about lung cancer causes and risk factors, as well as the need for screening among eligible patient populations.